DISCOUNT-OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 20:45:02 24/05/2024 BST | ||
| 0.54 EUR | -1.82% |
|
| Current month | -69.49% | ||
| 1 month | -70.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 0.54 | -1.82% |
| 23/05/24 | 0.55 | +37.50% |
| 22/05/24 | 0.4 | +29.03% |
| 21/05/24 | 0.31 | -13.89% |
| 20/05/24 | 0.36 | -5.26% |
Real-time BOERSE MUENCHEN
Last update May 24, 2024 at 08:45 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD4KBG |
| ISIN | DE000HD4KBG3 |
| Date issued | 11/04/2024 |
| Strike | 305 $ |
| Maturity | 19/06/2024 (24 Days) |
| Parity | 10 : 1 |
| Emission price | 1.97 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.03 € |
|---|---|
| Lowest since issue | 0.28 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
